OrbiMed is a healthcare-focused investment firm based in New York, founded in 1989, with approximately $5 billion in assets under management. It engages in private equity, venture capital, and growth investments across the global healthcare landscape, spanning biopharmaceuticals, biotechnology, life sciences tools, medical devices, diagnostics, health care services, and digital health. The firm invests across the development spectrum, from startup ventures to mature companies, and pursues opportunities worldwide, including North America, Europe, Asia, Israel and India, leveraging a long-standing specialization in the sector. Through its diversified capital programs, OrbiMed partners with management to advance innovative therapies, tools, and services that address significant medical needs.

General Catalyst is a venture capital firm founded in 2000 that provides early-stage and growth equity investments in technology companies. It supports portfolio companies with momentum and mentorship to accelerate growth toward long-term success and typically engages across seed to growth stages, potentially taking minority or majority stakes. The firm targets a broad range of sectors enabled by software and technology, including consumer, enterprise, fintech, crypto, healthcare IT, and related areas, and maintains a multi-region presence with offices in North America and Europe to back companies as they scale globally.

SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995, that focuses on seed to growth investments in deep technology across health, environmental tech, hardware, robotics, and cross border software, with a particular emphasis on Asia. The company runs accelerator style startup development programs, including HAX and IndieBio, which provide facilities, engineering resources, and lab equipment to help founders accelerate product development, acquire customers, and attract later stage funding. SOSV pursues a limited number of high potential startups, offering extensive hands on support to speed commercialization and scale, and aims to back innovations that improve human and planetary health.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, established in 2013. It targets individual accredited investors who previously had limited access to venture capital by enabling alumni from top entrepreneurial schools to invest together in ventures led by fellow alumni. The firm backs companies with an alumni connection and an institutional lead investor with sector expertise. It offers focused funds that provide accredited investors access to a diversified venture portfolio by type, sector, stage, and geography. The organization engages in seed, early-stage, and late-stage pre-IPO investments across technology, consumer, financial services, health care, life sciences, and other sectors.

RA Capital Management is a Boston-based investment firm that specializes in life sciences and healthcare companies. The firm provides investment management and venture capital services, backing companies developing drugs, medical devices, diagnostics, and biotech tools. Its team combines expertise in biology, chemistry, and medicine with industry and business development experience. RA Capital supports companies across multiple stages, from seed funding to growth financings, including private and public rounds, and often takes board seats and seeks co-investment opportunities. Through its activity, it aims to identify technologies with potential to advance prevention and treatment, genetic testing and personalized medicine, and other patient-focused innovations.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

Andreessen Horowitz is a venture capital firm based in Menlo Park, California. Founded in 2009 by Marc Andreessen and Ben Horowitz, it funds software and technology companies across seed to growth stages, with emphasis on web and mobile applications, cloud infrastructure, enterprise software, fintech, consumer Internet, artificial intelligence, and biotech-adjacent ventures. The firm focuses on technology-enabled businesses and provides strategic support and networks to portfolio companies.

Novo Nordisk is a global healthcare company that develops, manufactures, and distributes insulin and other diabetes medicines to treat chronic diseases. It pursues scientific breakthroughs and aims to expand access to its medicines, with the ultimate goal of preventing and curing disease.

Deerfield Management is a New York-based investment management firm founded in 1994 that focuses on healthcare. It engages in long-term structured investments in both public and private healthcare companies, and operates across investment activities, information services, and philanthropy. It acts as an investment adviser and supports private and public investments across life sciences, medical devices, diagnostics, digital health, and health services.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2010 that invests in early-stage technology startups. It specializes in pre-seed and seed rounds for capital-efficient companies, with a focus on the United States and Canada and occasional activity in Western Europe, Israel, Australia, and New Zealand. The firm typically makes 75 to 100 investments per year, with round sizes from 50,000 to 500,000 and pre-money valuations ranging from 1,000,000 to 3,500,000. Portfolio companies are typically located outside the San Francisco Bay Area and New York City, and the firm aims to provide a clear yes or no on opportunities within about two weeks.

StartUp Health is a health innovation platform founded in 2011 that supports a global portfolio of health technology companies through a network of entrepreneurs known as Health Transformers. Its mission is to achieve health moonshots by advancing solutions across Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. The organization oversees more than 330 portfolio companies across six continents and 26 countries, working with leading health systems and investors to accelerate adoption and impact. By connecting entrepreneurs with health systems, researchers, and investors, StartUp Health aims to improve the health and wellbeing of people worldwide and transform healthcare delivery over a multi-decade timeframe.

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines across neuroscience, cardiometabolic diseases, cancer, and immunology. It operates manufacturing and research facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The portfolio includes Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant, reflecting a diversified, science‑driven approach. In addition to human medicines, Lilly conducts research in animal health to treat animal diseases and support agricultural productivity. The company maintains a strong emphasis on research and development to address unmet medical needs and to bring innovative therapies to patients worldwide.

Maverick Capital is a global investment firm established in 1993 that manages capital through long/short hedged equity strategies and private investments, with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. The firm seeks to grow and preserve capital for qualified investors, conducting deep fundamental research and actively partnering with portfolio companies to support growth, including deploying resources and taking board seats. Maverick Capital also operates Maverick Ventures, its venture arm based in San Francisco, which funds startups from seed through growth across healthcare, software and deep technology, leveraging the parent firm’s resources and experience to help entrepreneurs build scalable businesses.

Antler is a global venture capital firm based in Singapore that backs early-stage technology companies. It runs incubation programs and provides a global community of co-founders, access to talent, expert advisors, expansion support, and capital to help startups grow. The firm targets a broad range of sectors, including healthcare, finance, software, energy, consumer and B2B technologies, and operates through regional programs across Europe, the United States, the United Kingdom, Southeast Asia, India, Africa, and beyond.

F-Prime Capital is a venture capital investment firm based in Cambridge, Massachusetts. Founded in 1969 with roots in Fidelity Investments, it backs entrepreneurs across technology and life sciences, investing in sectors such as crypto, enterprise information technology, fintech, frontier technologies, health information technology and services, medtech and therapeutics, with a global reach across the Americas, Europe and Asia.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages USD and RMB funds totaling about 9.5 billion in capital and backs early- and growth-stage technology, consumer, and healthcare companies. The firm has backed more than 530 portfolio companies, with over 200 exits via IPOs or M&A, and more than 70 unicorn or super unicorn companies.

Venrock is a Palo Alto-based venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. It concentrates on seed and early-stage technology and healthcare investments and has backed landmark companies such as Apple Computer, Intel, Illumina, Gilead Sciences, Athenahealth, DoubleClick, Nest, SlideShare, and Tudou. The firm manages multiple funds and maintains a US-focused investment approach, supporting entrepreneurs across information technology, life sciences, and related sectors throughout their growth journey.

The Blue Venture Fund is the corporate venture capital arm of the BlueCross BlueShield Association, based in Chicago. It invests in healthcare technology, healthcare services, and clinical sciences companies with the potential to improve care quality, patient experience, and cost efficiency, and seeks opportunities that align with the needs of BCBS member companies and their policyholders to foster innovation within the healthcare system.

Bessemer Venture Partners is a global venture capital firm founded in 1911 and headquartered in Redwood City, California. It backs startups across seed to growth stages, focusing on software, cloud, cybersecurity, fintech, consumer and healthcare technologies, and high-growth business models. The firm operates internationally, supporting portfolio companies from early product development through scale, and has backed well-known names such as Pinterest, Shopify, Twilio, Yelp, LinkedIn, Wix and others. BVP emphasizes helping founders establish durable foundations and guides companies through multiple growth phases, leveraging hands-on operational support, strategic networks, and cross-border expertise. With a diversified approach that includes consumer, enterprise and deep-tech investments, the firm seeks to build lasting companies that matter across global markets.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. The firm backs entrepreneurs with venture assistance, strategic guidance, and capital, focusing on bold, early-stage technology companies. It invests across sectors including AI, climate and sustainability, enterprise software, consumer technologies, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technologies. Based in Menlo Park, the firm manages several funds to support startups across stages, prioritizing ventures that address large markets and have potential for significant social and economic impact.

Joyance Partners is a San Francisco-based venture capital firm that backs early-stage startups in technology, health tech, consumer, internet, and mobile sectors across North America, Europe, and Asia. Founded in 2012, the firm seeks companies that, through science and technology, cultivate joy and improve how people live, with emphasis on health and consumer applications from pre-seed to Series A.

Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Lightspeed Venture Partners is a global venture capital firm based in Menlo Park, California, with additional offices in Beijing, Shanghai, New Delhi, and Israel. The firm backs early and growth stage start-ups across sectors such as enterprise software, consumer technology, fintech, healthtech, cleantech, and information technology, and pursues opportunities in the United States, Asia, and Israel. It funds a broad range of rounds, including seed, early, later, and expansion, and also provides debt financing for start-ups and growth companies. Lightspeed focuses on helping entrepreneurs scale through capital, strategic guidance, and operational support, and maintains a diversified portfolio across enterprise, consumer, big data, mobile, and internet-enabled sectors.

BoxGroup is a New York-based venture capital firm that backs early-stage technology startups, typically investing in pre-seed to Series A rounds. It supports companies across consumer, enterprise, fintech, healthcare, life sciences, marketplaces, and related sectors, prioritizing teams with strong vision and momentum. The firm seeks entrepreneurs launching movements in existing markets or creating new ones and aims to help category-defining businesses at the outset. While geographically active in major innovation hubs, BoxGroup evaluates opportunities across the United States and beyond, with a preference for early involvement and smaller initial checks.

8VC is a technology and life sciences investment firm based in San Francisco that partners with founders to develop transformational technologies. The firm aims to create long-term economic and societal value through its investments, spanning healthcare, energy, consumer goods, financial services, infrastructure, information technology, manufacturing, enterprise, logistics, defense, and other sectors. By backing ambitious teams and providing strategic support, 8VC seeks to enable industry transformation and global innovation.

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011, that manages investment portfolios and provides asset management services to clients across sectors, with a focus on software as a service companies, and analyzes market trends to inform its investment decisions while operating in finance, technology, and real estate.

Oak HC/FT is a Stamford, Connecticut-based venture and growth equity firm that concentrates on healthcare information services and financial technology. It supports entrepreneurs with strategic counsel, board‑level participation, and access to an extensive network of industry leaders to drive transformation in these sectors. The firm draws on Oak Investment Partners’ sector expertise to build and grow innovative businesses, with a history of notable exits and large valuations. Founded in 2014, Oak HC/FT targets both growth‑stage and early‑stage companies in the United States, aiming to deliver strong value for investors.

Optum is a health services and innovation company dedicated to helping people live healthier lives. It designs a healthcare system that connects people, places, and ideas across the ecosystem to deliver personalized care, including medication, healthcare financial services, and guidance, along with technology and services for health plan providers. The company offers a broad range of medical services, including family medicine, internal medicine, pediatrics, women's health, substance use treatment, and mental health, as well as care for common conditions of the eyes, ears, skin, and nervous system. By integrating data, insights, and digital tools, Optum seeks to improve access, care coordination, and the efficiency of the medical system for patients, providers, and employers in collaboration with health plans and other partners.

Ulu Ventures is a Palo Alto, California-based seed- and early-stage venture capital firm focused on technology-driven startups across IT, software, internet-enabled services, EdTech, FinTech, IoT, digital media, and related sectors in the United States, with a Bay Area emphasis. Founded in 2008, the firm backs diverse entrepreneurial teams and frequently co-invests with other angels or venture funds in early rounds. Ulu is noted as the first Latina-led venture fund in Silicon Valley and is among the largest in the country by assets under management, with over $200M.

Norwest Venture Partners is a global technology venture capital and growth equity firm founded in 1961 and based in California. The firm backs seed through growth-stage companies across the United States, India and Israel, with investments spanning technology, cloud and IT infrastructure, Internet and consumer products, SaaS, business services, financial services, healthcare, and other sectors. It has funded hundreds of companies and leverages a broad network and operating experience to help founders scale their businesses. Norwest pursues a flexible, long-term approach, tailoring its capital and support to each stage and company, and it deploys capital across multiple rounds from early checks to growth investments. The firm is known for partnering with CEOs and management teams to accelerate growth through strategic guidance, operational resources, and access to its portfolio network.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization founded in 1982 that supports the region's technology ecosystem. Based in Philadelphia, it acts as a capital provider and catalyst for early-stage and growing technology companies across information technology, health, and physical sciences by offering seed-stage funding and related resources to accelerate commercialization. The organization facilitates university–industry partnerships and regional initiatives that connect scientific research with market opportunities, with the aim of creating jobs and strengthening entrepreneurial communities in Southeastern Pennsylvania. Through its programs and partnerships, it supports adoption of new technologies and helps build a robust regional innovation ecosystem.

Merck & Co. is a global biopharmaceutical company that develops medicines and vaccines across multiple therapeutic areas, including cardiometabolic disease, cancer, and infectious diseases. The company’s cancer program centers on immuno-oncology with Keytruda, and its vaccines business includes Gardasil and pediatric vaccines. Merck also engages in animal health products and maintains a significant US presence, with a substantial share of sales generated in the United States. Headquartered in New Jersey, Merck focuses on research and development to discover and deliver innovative therapies that improve patient outcomes worldwide.

Hatteras Venture Partners is a Durham, North Carolina-based venture capital and private equity firm founded in 2000 that focuses on funding life sciences and healthcare companies in the United States. Its activities center on biopharmaceuticals, medical devices, diagnostics, healthcare information technology, and related human medicine opportunities, with investments spanning pre-seed to growth stages. The firm typically makes initial investments in the range of half a million to four million dollars and participates in follow-on rounds up to around twenty million, and it operates as a Small Business Investment Company (SBIC). Hatteras also backs adjacent sectors such as software and health services within the Southeast, leveraging an experienced team to support value creation in early-stage biomedical ventures.

Vivo Capital is a healthcare-focused investment firm founded in 1996 and headquartered in Palo Alto, California, with offices in Asia. The firm operates a multi-strategy platform including growth equity, private equity, venture capital, and public equity, and invests across biopharmaceuticals, specialty pharmaceuticals, medical devices, diagnostics, and healthcare services. It pursues opportunities globally, including the United States and China, and has invested in more than 290 companies. The team comprises physicians, scientists, entrepreneurs, operating executives, and industry experts, and the firm manages about $5.8 billion in assets.

FJ Labs is a New York-based venture capital firm founded in 2015 by Fabrice Grinda. It is stage-agnostic and focuses on marketplaces and consumer-facing startups, making seed and Series A investments. Typical checks range from 50,000 to 5,000,000 dollars. The firm supports early-stage companies across sectors such as e-commerce, fintech, ad tech, mobile, and software-as-a-service, seeking opportunities with high growth potential in the United States and internationally. Its portfolio includes a mix of consumer brands and marketplace platforms, reflecting an emphasis on business models that connect buyers and sellers or enable direct consumer experiences. FJ Labs aims to back entrepreneurs building scalable, disruptively positioned products and services, often partnering with founders early in their development to help accelerate growth.

First Round Capital is a San Francisco-based seed-stage venture capital firm that backs technology startups from pre-seed through Series A. It offers capital, a founder-focused community, and services designed to help companies grow from inception, with partners who take an active role in portfolio companies. The firm invests nationally across sectors including healthcare, consumer technology, fintech, hardware, artificial intelligence, and web3, with offices in San Francisco and New York. It emphasizes resources beyond funding and has adopted a diversity term sheet rider to promote inclusive entrepreneurship.

UPMC is a nonprofit health system and integrated global health enterprise headquartered in Pittsburgh, Pennsylvania. It develops and delivers Life Changing Medicine by leveraging technology, translating science into cures, and accelerating innovation worldwide. The organization includes UPMC Health Plan, a large insurer serving hundreds of thousands of members with commercial and government programs, a broad provider network, and high-quality care as indicated by NCQA ratings. Through its hospitals and physicians, UPMC pursues accessible, high-value health care and wellness solutions, supported by a mission to advance medicine through research and collaboration.

Pfizer is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines across a broad range of therapeutic areas. It maintains an extensive portfolio of prescription drugs and vaccines, with notable products such as Prevnar 13, Ibrance, and Eliquis. The company serves customers worldwide, with substantial international and emerging-market sales. Through ongoing research and development, Pfizer pursues new treatments to address major diseases, including cancer and neurodegenerative conditions, and aims to improve patient outcomes by delivering safe, effective, and accessible therapies. Founded in 1849 and headquartered in the United States, Pfizer operates globally to advance health care through science, partnerships, and scalable manufacturing capabilities.

IMM Investment is a Seoul-based independent private equity and venture capital firm established in 1999. The company engages in mezzanine and growth investments and pursues opportunities in mergers and acquisitions, venture capital, corporate restructuring, private equity, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border transactions. It concentrates on medium-sized companies operating in information technology infrastructure, wireless communications, software, contents, and other technology-enabled sectors, with a particular emphasis on information technology, healthcare/biotech, and manufacturing. The firm typically takes an active role in governance and strategic direction and focuses on opportunities within South Korea and cross-border contexts. IMM Investment aims to support portfolio companies through growth, expansion, and consolidation, leveraging its long-standing relationships with institutional investors and investment professionals.

Atlas Venture is a Cambridge, Massachusetts–based venture capital firm founded in 1980 that specializes in life sciences and technology. It pursues seed-led venture creation and early-stage investments to build scalable companies in biopharmaceuticals, diagnostics, medical devices, and related biomedical technologies, as well as software and other technology sectors. The firm often leads investments and seeks board representation to support portfolio companies as they grow toward acquisition or public offerings. Atlas operates with dedicated life sciences and technology teams and maintains an international footprint across the United States and Europe.

Samsara BioCapital is a Palo Alto-based venture capital firm founded in 2016 that focuses on the healthcare sector, including biotechnology, pharmaceuticals, oncology, and life sciences. The firm seeks opportunities in the United States and provides investment advisory services as part of its activities, supporting companies developing innovative therapies and related technologies.

Headline is a San Francisco based venture capital firm founded in 1998 that operates globally with a presence in seven cities and leads rounds across stages. It maintains a multi fund approach, with Early Stage funds across the US, Europe, Asia and Brazil and a Growth Fund based in San Francisco that backs companies from Series B onward, enabling it to identify local trends and back scale across geographies. The firm backs a broad range of sectors including consumer, media, financial services, healthcare, information technology, SaaS, cybersecurity, e commerce, artificial intelligence and digital health, and has a notable portfolio featuring Sonos, The RealReal, Creditas, Sorare, Pismo, AppFolio, GoPuff, Acorns, Farfetch, Segment, Bumble and Yeahka. Headline also runs an Asia arm, Headline Asia, based in Tokyo, investing in East, South and Southeast Asia across B2B, media, fintech, healthcare, IT, e commerce, AI and other sectors, with activity including a 2020 vintage Asia IV fund focused on the region. Headline positions itself as a global, founder friendly investor that seeks to partner with ambitious entrepreneurs to build lasting companies.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Triventures is a global venture capital firm established in 2010, headquartered in Herzliya/ Tel Aviv, Israel, with offices in California, United States. The firm backs startups led by exceptional entrepreneurs and focuses on early-stage to growth-stage investments across healthcare, wellness, big data, artificial intelligence and machine learning, and broader technology sectors. Its portfolio emphasizes healthcare devices and digital health, medical technologies, health data marketplaces, and cross‑industry applications that combine health with other domains such as insurtech, fintech for healthcare, e-commerce, and cybersecurity for healthcare. With a team of professionals drawn from healthcare, entrepreneurship, venture and corporate development, Triventures aims to identify breakthroughs at the intersection of health and non-health technology and to leverage deep sector expertise to support portfolio companies across Israel, the United States, and Europe.

Global Founders Capital is a Berlin, Germany-based venture capital firm with a global focus that invests across seed, early, and later-stage companies. It maintains a stage-agnostic approach, seeking innovative ideas with potential impact and feasibility in global markets.

ARCH Venture Partners is a United States-based venture capital firm founded in 1986 and headquartered in Chicago, Illinois. The firm focuses on science-driven companies, with a track record of commercializing technologies developed at academic research institutions and national laboratories. It primarily invests in life sciences, biotechnology, pharmaceuticals, healthcare technology, and related sectors, and also backs software, materials, clean tech, and information technology across early to growth stages. ARCH emphasizes relationships with scientists and entrepreneurs, often taking early stakes and supporting subsequent rounds to help market entry and scale. The firm has raised multiple venture funds totaling several billion dollars and maintains a national and international reach with offices across North America.

Sofinnova Partners is an independent venture capital firm based in Paris, France, focusing on life sciences from seed to later-stage investments. It backs startups, early-stage companies, corporate spin-offs and occasionally turnaround situations in biopharmaceuticals/biotech, medical devices, and industrial biotechnology. The firm typically takes a lead or cornerstone role, often serving as the first institutional investor in Series A rounds, and actively supports portfolio companies through formation and beyond, including board participation. The firm manages more than €2 billion in life sciences assets.

Versant Ventures is a healthcare-focused venture capital firm founded in 1999 and based in San Francisco, with offices in Canada, the United States and Europe. The firm invests across the healthcare sector at all stages, with an emphasis on discovery and development of novel therapeutics, and portfolios spanning biotechnology, pharmaceuticals, life sciences, healthcare devices and healthtech. Versant combines deep investment, operating and scientific expertise to support entrepreneurs through hands-on company building. It has backed more than 65 portfolio companies that have achieved acquisitions or IPOs.

McKesson Corporation provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry, operating in two segments. The company distributes medical supplies through its McKesson Medical-Surgical unit, offering medical supplies, healthcare solutions, distribution services and clinical resources, and provides pharmacy outsourcing services to hospitals through McKesson Medication Management, supporting healthcare providers, pharmacies and patients by delivering products and enabling information flow and care management across the healthcare system.